Navigation Links
AnkleWALKER™ by DJ!

ProductsAnkleWALKER™ by DJ!
Company AliMed, Inc.
Item AnkleWALKER™ by DJ!
Features 
  • Lightweight, one-piece, injection-molded construction
  • Low-profile design with nonskid rockerbottom sole
  • Integrated straps for full circumferential compression
  • Breathable fiber liner with sewn-in heel pad for comfort
  • Description AnkleWALKER™ Shorter uprights and circumferential plastic shell inhibit foot and ankle motion. Designed to provide comfortable stability for acute ankle sprains, soft tissue injuries, stress and stable fractures of the foot.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. Achilles Tendon Walker and Replacement Insoles
    2. Bledsoe Wee Walker Boot
    3. PneumaticWalker™ Diabetic System
    4. FoamWalker™
    5. SP Walker™
    6. PneumaticWalker™
    7. Anklizer® Low Profile Walker-Fixed Ankle
    8. Anklizer® II Low Profile Walker-Fixed Ankle
    9. Ultra Lower Leg Walker
    10. Cam Walker® II
    11. MaxTrax Walker
    ...st is an ELISA method for the qualitative detectio...id antigen (VCA) in human serum. When the VCA IgG ...h as the EBV nuclear antigen (EBNA-1), VCA IgM, an..., the results can serve as an aid in the diagnosis...
    The ImmunoDOT Borrelia (Lyme) test is an enzyme immunoassay (EIA) dot-blot test for the qualitative detection of borrelia antibodies. Both,species specific (anti-P39) and related Borrelia burgdorfe
    The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u
    The ImmunoWELL Thyroglobulin IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroglobulin in serum and is used as an aid
    Medicine Products:
    (Date:7/18/2008)... 18 /PRNewswire/ -- minSURG Corporation,producers...n procedure,announced today the creation of minSU...division has been established in response to globa... CEO, Jim Doulgeris said, "Distributors from Canad...ds, Singapore, Taiwan, Turkey and Japan have,expre...
    (Date:7/18/2008)...ch into the earliest events occurring immediately ...ls a stunning blow to the immune system earlier th...sts at Duke University Medical Center, this sugges...ention may be only a matter of days not weeks af...lieved. , Appearing in the August issue of the ...
    (Date:7/18/2008).../PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC,Bul... in the development,and commercialization of anti-...l implants, announced today the appointment of Ms....irector, International Market Development.,Ms. Mun...years of sales,sales management and market develo...
    (Date:7/18/2008)...Leading long-term care software companies offer se...ons systems. , Indianapol...veloper of Clinical Management Software for the lo...s, a national provider of patient referral softwar...rtnership to help long term care facilities effici...
    Breaking Medicine News(10 mins):Health News:minSURG(TM) Corporation Launches International Division 2Health News:HIV conquers immune system faster than previously realized 2Health News:HIV conquers immune system faster than previously realized 3Health News:SyntheMed Appoints Corinne Mundin as Director, International Market Development 2Health News:SyntheMed Appoints Corinne Mundin as Director, International Market Development 3Health News:Qtrac Software and Patient Placement Systems Announce Partnership and Healthcare Data Interface 2Health News:Qtrac Software and Patient Placement Systems Announce Partnership and Healthcare Data Interface 3
    ...th in a West Bengal hospital is brandishing a piec... that is attracting hundreds of curious visitors//...i, 40 km north of Kolkata in Nadia district, has n...days with electrician Sambhu Roy, who suffered sev...
    ...ary Harney has plans to introduce new legislation ...e next week or so//. She is seeking Government app...gislation next week or the following week so that ...l can be published later this year. Although chang...
    ...nderbilt University Medical Center are attempting ...sease by implanting stimulation devices //into the...course of their disease. 'One of the driving theor...ty that if deep brain stimulation (DBS) therapy wa...
    ...ing the skin’s aging process, but Igor Sokolov, a ...believe your skin has to look as old as you are//....pithelial tissues lose elasticity with aging, but ... the reasons. Chemical & Engineering News magazine...
    Other Medicine News:Health News:Man Holds Own Skull in Bengal Medical Miracle 2Health News:Researchers Try Early Surgical Intervention to Treat Parkinson's Symptoms 2Health News:Researchers Try Early Surgical Intervention to Treat Parkinson's Symptoms 3Health News:"Anti Aging" Skin Cream Developed at Clarkson University 2
    (Date:7/17/2008)...wswire/ -- The research team at the,Nemours Center...tablished,division of Nemours Biomedical Research ...discovered that the biomarker called prostate spec...n cancer cells of patients,with advanced prostate ...,of cancer to an aggressive disease. A biomarker i...
    (Date:7/17/2008)...swire/ -- Impliant, Inc., a developer of,novel spi...day announced,that it conducted the first surgery ... of its TOPS(TM) System, a Total Posterior,Arthrop...h or without facet,arthrosis and spondylolisthesis...Neurosurgeon at the Charlotte Neurosurgery and Spi...
    (Date:7/17/2008)...swire-USNewswire/ -- Strong National,Museum of Pla... the,American Journal of Play, the first interdisc...study of play., The inaugural issue enters the sc...ontent from some of the most prominent national,re...ientist,s assertion,that the rising tide of ADHD a...
    (Date:7/17/2008)...ly 17 /- Anesiva,Inc. (Nas...hase 2 clinical,trial of Adlea(TM), the company,s ...ate for the management of acute pain in patients u...rotator cuff repair., Adlea is currently in two p...ee replacement surgeries and one in bunionectomy s...
    Breaking Medicine Technology:Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 2Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer 3Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System 2Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008 2Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery 2Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery 3Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery 4Lorus Therapeutics Provides an Update on Progress in Virulizin 28R 29 Development Program 6447 1Lorus Therapeutics Provides an Update on Progress in Virulizin 28R 29 Development Program 6447 2Lorus Therapeutics Provides an Update on Progress in Virulizin 28R 29 Development Program 6447 3Lorus Therapeutics Provides an Update on Progress in Virulizin 28R 29 Development Program 6447 4Lorus Therapeutics Provides an Update on Progress in Virulizin 28R 29 Development Program 6447 5Lorus Therapeutics Provides an Update on Progress in Virulizin 28R 29 Development Program 6447 6Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 1Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 2Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President Global Supply Chain and Sustainment Engineering 6445 3Ardea Biosciences Advances RDEA806 Into Phase 2a Proof of Concept Study for Gout 6443 1Ardea Biosciences Advances RDEA806 Into Phase 2a Proof of Concept Study for Gout 6443 2Ardea Biosciences Advances RDEA806 Into Phase 2a Proof of Concept Study for Gout 6443 3Ardea Biosciences Advances RDEA806 Into Phase 2a Proof of Concept Study for Gout 6443 4Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect 28R 29 28Basiliximab 29 for Noninfectious Uveitis 2603 1Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect 28R 29 28Basiliximab 29 for Noninfectious Uveitis 2603 2
    ...007 - Alequel(TM), an,individualized oral immune r...nt for moderate-to-severe Crohn,s disease. Interim...olled Phase II,studies suggest that this investiga...nd improved patients, quality of life compared,to ...y-Hadassah,Medical Center, Jerusalem, Israel, will...
    ...22, 2007 - The National,Comprehensive Cancer Netwo...ractice Guidelines in Oncology(TM) -- Esophageal C...updated continuously by,panels of world-renowned e...e standard of care in oncology in the United State...settings., In response to favorable Phase III tria...
    Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3NCCN Updates Esophageal and Gastric Cancer Guidelines 2NCCN Updates Esophageal and Gastric Cancer Guidelines 3